Document Detail

Comparative study of extra-amniotic prostaglandin F2 alpha infusion and increasing intravenous oxytocin for termination of second trimester missed abortion.
MedLine Citation:
PMID:  8167879     Owner:  NLM     Status:  MEDLINE    
Extra-amniotic infusion of prostaglandin F2 alpha (PGF2 alpha) and intravenous (IV) oxytocin in increasing doses were compared in a retrospective study to establish the efficacy of the two methods for termination of pregnancies with second trimester missed abortion. Sixty women with this complication underwent pregnancy termination, 28 by extra-amniotic infusion of PGF2 alpha and oxytocin augmentation, if necessary, and 32 by IV oxytocin in increasing doses. All patients in the PGF2 alpha group aborted within 24 hours from onset of infusion and seven of them needed oxytocin augmentation. There were nine failures in the oxytocin group and the other 23 aborted within 17 hours. The mean (plus or minus standard error of the mean) induction-abortion interval was significantly less in the oxytocin group (6.9 +/- 3.4 hours) than in the PGF2 alpha group (12.6 +/- 5.7 hours) p < 0.001. Eight patients in the group had mild side effects, such as nausea, flushes or transient hypotension. Uterine hypertonus was observed in two women receiving PGF2 alpha and treated by temporary interruption of the infusion. In the oxytocin group, one patient had coagulation disturbances and one, hemorrhage. We conclude that extra-amniotic PGF2 alpha infusion is more effective than IV oxytocin in increasing doses, for termination of second trimester missed abortion, but takes effect more slowly. We can assume that further use of IV oxytocin immediately after termination of the PGF2 alpha administration can shorten the induction-abortion interval.
O E Jaschevatzky; R P Rosenberg; Y Noy; S Dascalu; S Anderman; S Ballas
Related Documents :
8863909 - Oral misoprostol use in early complicated pregnancy.
25332049 - Recurrent brain tumor with hydrocephalus in pregnancy.
12289529 - Order on the guidance file provided for in article l. 162-3 of the public health code, ...
2744189 - Circulating levels of placental protein 14 and progesterone following mifepristone (ru3...
14624219 - Misoprostol and pregnancy: ever-increasing indications of effective usage.
17131609 - Exploration of the views of traditional healers regarding the termination of pregnancy ...
21485729 - Troponin i, c-reactive protein and fibrinogen levels in missed abortions.
2643149 - Transabdominal versus endovaginal pelvic sonography: prospective study.
21343759 - Number of oral contraceptive pill packages dispensed and subsequent unintended pregnanc...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Journal of the American College of Surgeons     Volume:  178     ISSN:  1072-7515     ISO Abbreviation:  J. Am. Coll. Surg.     Publication Date:  1994 May 
Date Detail:
Created Date:  1994-06-02     Completed Date:  1994-06-02     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9431305     Medline TA:  J Am Coll Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  435-8     Citation Subset:  AIM; IM; J    
Department of Obstetrics and Gynecology, Hillel Jaffe Medical Center, Hadera, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Abortion, Missed / drug therapy*
Dinoprost / administration & dosage,  therapeutic use*
Infusions, Intravenous
Oxytocin / administration & dosage,  therapeutic use*
Pregnancy Trimester, Second
Retrospective Studies
Reg. No./Substance:
50-56-6/Oxytocin; 551-11-1/Dinoprost

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Hemodialysis graft salvage.
Next Document:  Angiographic catheter induced arterial occlusion.